Refreshing results…
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
Download from doi.orgBurkitt Lymphoma International Prognostic Index
Download from doi.orgMissing publications? Search for publications with a matching author name.